Evolving Cannabis Industry Potential and Constellation Investment Overview
Cannabis as a Potentially Disruptive Ingredient
CANOPY GROWTH
Constellation
Brands
CORPORATION
Cannabis is the New Frontier of Human and
Animal Health
Global
Ахәлира
BECKLEY
CANOPY
THERAPEUTICS
Sleep - $10bn
Pain - $24bn
Anxiety - $5bn
MS - $18bn
Psoriasis $8bn
IP Protection
39
Patent Applications
filed with USPTO
Base
New Markets to Drive Incremental Growth
Market
Population of
Adult Consumers
Consumption
Volume in
Grams per
Consumer
Develop and
validate
cannabinoid based
medicines as a
Formulation,
$
canopy health
INNOVATIONS
Price per Gram
of Marijuana
safer alternative to
current treatments
Based
Dosing &
Ancillary
Market
Potential
Upside
$+
+ A
Security
Growers
Infused Product
Testing Labs
Makers
☑+
Π
貝
Tourism
Revenue
Business Taxes License Fees
Paraphernalia
Source: Deloitte Industry Report, Company information
Indications
Commerci
Licensing
Phase II Sleep
Trial
Approved
Animal Anxiety
Canopy Growth
has the first right
to commercialize
CANOPY GROWTH
CORPORATION
IP that is
developed by
Canopy Health
Study
Approved
| 11View entire presentation